During February 2016, the EMA set up a Zika Virus task force in a bid to aid global efforts to respond to the emerging epidemic. The task force consisted of European experts
18 Jan, 2017
18 Jan, 2017
Over the year, there has been a steady increase of microbes resistance to antimicrobial treatments, leading to a growing global public health concern. This resistance is
18 Jan, 2017
The Ebola epidemic in West Africa broke out in Guinea in March 2014, spreading rapidly to Liberia and Sierra Leone. In total, the virus spread to 9 countries resulting in
The MHRA issued updated guidance that aims to identify a healthcare app that fulfils medical device regulations, confirming its safety. Users are able to check if their health
18 Jan, 2017
The increase in the numbers of pharmacies is in part because of the increase in applications for 100-hour and more recently, internet or distance selling pharmacies. There is
18 Jan, 2017
It is estimated about 2.5 million people are infected with HIV every year and with no vaccine or cure for AIDS, prevention is the prime focus in the battle against this
The pharmacovigilance and regulatory scene saw many interesting developments in 2016, not least the UK’s vote to leave the EU back in June. Advances were also made in drug
18 Jan, 2017
Another year has drawn to a close and what an eventful year it has been for the regulators! Both the EMA and MHRA were involved in many due diligence activities. We look back
03 Jan, 2017
This webinar discusses causality assessments and algorithms available with the view to obtaining consistency in decision making for cases and for safety issues.
Pharmacoepidemiological studies are becoming more prevalent in the post-marketing pharmacovigilance world. This webinar will go through some basics on the types of
